These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15125310)

  • 21. Brief report: two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autism.
    Dartnall NA; Holmes JP; Morgan SN; McDougle CJ
    J Autism Dev Disord; 1999 Feb; 29(1):87-91. PubMed ID: 10097998
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy and safety of risperidone in psychotic patients: an open study.
    Daradkeh TK; Reda F; Karim L
    J Int Med Res; 1996; 24(3):291-5. PubMed ID: 8725991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study questions the benefit of the treatment. Aggressive Alzheimer patient -- a (not a) case for atypical neuroleptics?].
    Kurz A
    MMW Fortschr Med; 2006 Nov; 148(47):16. PubMed ID: 17168181
    [No Abstract]   [Full Text] [Related]  

  • 24. Paramenstrual aggression in mentally retarded adult ameliorated by buspirone.
    Colella RF; Ratey JJ; Glaser AI
    Int J Psychiatry Med; 1992; 22(4):351-6. PubMed ID: 1293064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risperidone for the treatment of fecal smearing in a developmentally disabled adult.
    Brahm NC; Farmer KC; Brown RC
    Am J Health Syst Pharm; 2007 Feb; 64(4):382-4. PubMed ID: 17299177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
    Villari V; Rocca P; Fonzo V; Montemagni C; Pandullo P; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):405-13. PubMed ID: 17900775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of aggression with risperidone in children and adolescents with bipolar disorder: a case series.
    Saxena K; Chang K; Steiner H
    Bipolar Disord; 2006 Aug; 8(4):405-10. PubMed ID: 16879141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hepatitis A in an institution for the mentally retarded in an intermediate endemicity area: influence of age length of institutionalization.
    Gil A; González A; Dal-Ré R; Dominguez V; Ortega P; Barrio JL; Aguilar L
    J Infect; 1999 Mar; 38(2):120-3. PubMed ID: 10342653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risperidone in the management of agitation and aggression associated with psychiatric disorders.
    De Deyn PP; Buitelaar J
    Eur Psychiatry; 2006 Jan; 21(1):21-8. PubMed ID: 16414250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
    Tune LE
    J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose risperidone augmentation of antidepressants in nonpsychotic depressive disorders with suicidal ideation.
    Viner MW; Chen Y; Bakshi I; Kamper P
    J Clin Psychopharmacol; 2003 Feb; 23(1):104-6. PubMed ID: 12544386
    [No Abstract]   [Full Text] [Related]  

  • 35. The Treatment of Severe Childhood Aggression Study: 12 Weeks of Extended, Blinded Treatment in Clinical Responders.
    Findling RL; Townsend L; Brown NV; Arnold LE; Gadow KD; Kolko DJ; McNamara NK; Gary DS; Kaplin DB; Farmer CA; Kipp H; Williams C; Butter EM; Bukstein OG; Rice R; Buchan-Page K; Molina BS; Aman MG
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):52-65. PubMed ID: 28212067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacotherapy for mental health problems in people with intellectual disability.
    Ji NY; Findling RL
    Curr Opin Psychiatry; 2016 Mar; 29(2):103-25. PubMed ID: 26779860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimum effective and relapse-associated doses of risperidone and olanzapine in aggressive, intellectually disabled adults.
    Janowsky DS; Hu Q; Buneviciute J; Davis JM
    J Clin Psychopharmacol; 2011 Apr; 31(2):238-40. PubMed ID: 21364333
    [No Abstract]   [Full Text] [Related]  

  • 38. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.
    Research Units on Pediatric Psychopharmacology Autism Network
    Am J Psychiatry; 2005 Jul; 162(7):1361-9. PubMed ID: 15994720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.
    Aman MG; De Smedt G; Derivan A; Lyons B; Findling RL;
    Am J Psychiatry; 2002 Aug; 159(8):1337-46. PubMed ID: 12153826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of long-acting risperidone in a patient with comorbid intellectual disability, catatonic schizophrenia, and oneiroid syndrome.
    Serata D; Rapinesi C; Kotzalidis GD; Alessi MC; Janiri D; Massolo AC; Ferri VR; Criscuolo S; Callovini G; Angeletti G; Girardi P; Del Casale A
    Int J Psychiatry Med; 2015; 50(3):251-6. PubMed ID: 26443711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.